COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Maciej Banach,Maria-Corina Serban,Amirhossein Sahebkar,Hector M. Garcia-Garcia,Dimitri P. Mikhailidis,Seth Martin,Brie Daniel,Jacek Rysz,Peter P. Toth,Steven R. Jones,Rani Hasan,Svetlana Mosteoru,Mahmoud Al Rifai,Michael J. Pencina,Patrick W. Serruys

COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

2016

Maciej Banach
Maria-Corina Serban
Amirhossein Sahebkar
Hector M. Garcia-Garcia
Dimitri P. Mikhailidis
Seth Martin
Brie Daniel
Jacek Rysz
Peter P. Toth
Steven R. Jones
Rani Hasan
Svetlana Mosteoru
Mahmoud Al Rifai
Michael J. Pencina
Patrick W. Serruys

Several studies suggest similar clinical outcomes between everolimus-eluting bioresorbable stents (BRS) ABSORB (Abbott Vascular, Santa Clara, CA) versus conventional drug-eluting stents (DES) and bare metallic stents (BMS), but the evidence is not definitive. We performed a systematic review and

Keywords:

Meta-analysis
Drug
Vascular stents
Surgery
Cardiology
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations